| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $70.33B | +32.4% |
| Cost of Revenue | $66.92B | +34.6% |
| Gross Profit | $3.41B | +0.5% |
| R&D Expense | $28.0M | -6.7% |
| SG&A Expense | $2.11B | +19.0% |
| Interest Expense | $628.0M | +33.3% |
| Pre-tax Income | $1.13B | -25.6% |
| Income Tax | $288.0M | -14.3% |
| Net Income | $816.0M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.14B | -65.7% |
| Short-term Investments | $861.0M | +77.9% |
| Accounts Receivable | $3.87B | +80.2% |
| Inventory | $13.20B | +103.3% |
| Current Assets | $24.39B | +52.8% |
| Total Assets | $44.53B | +78.8% |
| Current Liabilities | $15.13B | +103.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $844.0M | -55.6% |
| Capital Expenditures | $1.72B | +25.2% |
| Investing Cash Flow | -$5.23B | -369.2% |
| Financing Cash Flow | $2.23B | +2576.7% |
| Free Cash Flow | -$879.0M | -267.7% |
| -28.2% |
| EPS (Basic) | $4.95 | -38.8% |
| EPS (Diluted) | $4.91 | -38.5% |
| Long-term Debt |
| $10.17B |
| +89.6% |
| Stockholders' Equity | $15.90B | +60.4% |